CN102397391A - Drug for treating hypertension, hyperlipaemia and blood hyperviscosity and preparation method thereof - Google Patents

Drug for treating hypertension, hyperlipaemia and blood hyperviscosity and preparation method thereof Download PDF

Info

Publication number
CN102397391A
CN102397391A CN2011103368859A CN201110336885A CN102397391A CN 102397391 A CN102397391 A CN 102397391A CN 2011103368859 A CN2011103368859 A CN 2011103368859A CN 201110336885 A CN201110336885 A CN 201110336885A CN 102397391 A CN102397391 A CN 102397391A
Authority
CN
China
Prior art keywords
radix
blood
medicine
hyperlipidemia
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011103368859A
Other languages
Chinese (zh)
Inventor
贾瑞飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011103368859A priority Critical patent/CN102397391A/en
Publication of CN102397391A publication Critical patent/CN102397391A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a drug for treating hypertension, hyperlipaemia and blood hyperviscosity and a preparation method thereof. The medicine for treating hypertension, hyperlipaemia and blood hyperviscosity and preparation method thereof comprises the following raw materials in part by weight: 10 to 20 Salvia miltiorrhiza, 5 to 10 bark of tree peony root, 1 to 3 leech, 15 to 25 self-heal, 3 to 6 Chinese thorowax, 9 to 12 dried rhizome of rehmannia, 3 to 6 dried orange peel, 3 to 9 Magnolia officinalis, 3 to 9 Cocculus diversifolius Miq. and 6 to 12 hawthorn. Combined with needle therapy, compared with the prior art adopting western medicine to treat the hypertension, hyperlipaermia and the blood hyperviscosity, the method has advantages that the treatment efficiency is remarkable, the action is durable and stable, and no toxicity and side effect exists.

Description

Medicine of treatment hypertension, hyperlipidemia, high blood viscosity and preparation method thereof
Technical field
The present invention relates to medicine that cooperates acupuncture and moxibustion treatment treatment hypertension, hyperlipidemia, high blood viscosity and preparation method thereof.
Background technology
Diseases of cardiovascular and cerebrovascular systems such as hypertension, hyperlipidemia, high blood viscosity are a kind of commonly encountered diseases, frequently-occurring disease, also are a kind of mortality rate disease with high.The induced factor of this type disease as a rule, shows as that blood fat height, blood stickiness increase, blood flowing speed slows down, and influences the normal circulation of blood, thereby causes the generation of vascular system disease.
Along with understanding and the raising of modern medicine to acupuncture, acupuncture is of common occurrence clinically in the treatment that reduces cardiovascular and cerebrovascular diseases such as hypertension, have plenty of temporary, have plenty of permanent, have to obtain effect very fast, the effectiveness that has is slow.Effective reason of acupuncture, present stage medical science can not provide satisfied answer.It is generally acknowledged: regulate and the control higher nervous activity, adjusting vascular pressure system punctures little blood vessel, makes blood pressure drops.But at present, also do not cooperate the Chinese herbal and crude drugs preparations of acupuncture and moxibustion treatment to be used to treat hypertension, hyperlipidemia, high blood viscosity.
Summary of the invention
The present invention proposes a kind of new solution to the problem that above-mentioned Therapeutic Method exists.It is raw material that the present invention selects the pure natural Chinese herbal medicine for use, be prepared into conveniently take, obtain and imitate preparation fast, that cooperate acupuncture and moxibustion therapy hypertension, hyperlipidemia, high blood viscosity.Dredge the meridian passage of the present invention, blood pressure lowering, blood fat reducing improve blood circulation.
Solution provided by the invention is:
The medicine of treatment hypertension, hyperlipidemia, high blood viscosity, form by the raw material of following ratio of weight and number:
Radix Salviae Miltiorrhizae 10 ~ 20, Cortex Moutan 5 ~ 10, Hirudo 1 ~ 3, Spica Prunellae 15 ~ 25, Radix Bupleuri 3 ~ 6, the Radix Rehmanniae 9 ~ 12, Pericarpium Citri Reticulatae 3 ~ 6, Cortex Magnoliae Officinalis 3 ~ 9, Radix Stephaniae Tetrandrae 3 ~ 9, Fructus Crataegi 6 ~ 12.
Concrete, the medicine of said treatment hypertension, hyperlipidemia, high blood viscosity, form by the raw material of following ratio of weight and number:
Radix Salviae Miltiorrhizae 14 ~ 17, Cortex Moutan 7 ~ 8, Hirudo 1.6 ~ 2.3, Spica Prunellae 18 ~ 22, Radix Bupleuri 4 ~ 5, the Radix Rehmanniae 10 ~ 11, Pericarpium Citri Reticulatae 4 ~ 5, Cortex Magnoliae Officinalis 5 ~ 7, Radix Stephaniae Tetrandrae 3 ~ 7, Fructus Crataegi 7 ~ 10.
Concrete, the medicine of said treatment hypertension, hyperlipidemia, high blood viscosity, form by the raw material of following ratio of weight and number:
Radix Salviae Miltiorrhizae 15, Cortex Moutan 7, Hirudo 2, Spica Prunellae 20, Radix Bupleuri 4.5, the Radix Rehmanniae 10, Pericarpium Citri Reticulatae 4.5, Cortex Magnoliae Officinalis 6, Radix Stephaniae Tetrandrae 5, Fructus Crataegi 9.
The method for preparing of treatment hypertension, hyperlipidemia, high blood viscosity medicine,
1) raw material of the following ratio of weight and number of preparation: Radix Salviae Miltiorrhizae 10 ~ 20, Cortex Moutan 5 ~ 10, Hirudo 1 ~ 3, Spica Prunellae 15 ~ 25, Radix Bupleuri 3 ~ 6, the Radix Rehmanniae 9 ~ 12, Pericarpium Citri Reticulatae 3 ~ 6, Cortex Magnoliae Officinalis 3 ~ 9, Radix Stephaniae Tetrandrae 3 ~ 9, Fructus Crataegi 6 ~ 12;
2) raw material of above-mentioned preparation adopts industrial making method to be processed into tablet, powder, decoction, honeyed pill or capsule.
Radix Salviae Miltiorrhizae, Cortex Moutan, Hirudo removing blood stasis, blood circulation promoting and blood stasis dispelling and repercussive blood; Removing heat from the liver to lower the high blood pressure, relieving restlessness are calmed the nerves, logical blood circulation regulating, blood vessel dilating; The alleviating vascular spasm; Improve the blood vessel endothelium cellulose content, the viscosity of blood fat reducing and blood can make blood-retention or long-pending stagnation resolvation loose and be absorbed in the blood circulation or from stool and gush and separate.
Spica Prunellae, Radix Bupleuri, Radix Salviae Miltiorrhizae, Radix Rehmanniae nourshing blood and promoting blood circulation blood stasis dispelling and do not hinder fresh blood, depressed liver-energy dispersing and QI regulating, the promoting the circulation of blood resolving depression, removing heat from the liver to lower the high blood pressure is regulated unbalancely, leads the mechanism of qi operation of liver and gall off, and blood circulation promoting improves the nutritional status of blood, makes elevated blood pressure be able to descend.
The Rhizoma Pinelliae, Pericarpium Citri Reticulatae, Cortex Magnoliae Officinalis, Radix Stephaniae Tetrandrae, Fructus Crataegi invigorating spleen to remove dampness, drying dampness to eliminate phlegm, diuretic heat clearing away; The burnt blood system turbid damp of diarrhea, the unusual rising of blood fat is alleviated in the adjustment metabolism; Improve the high sticky blood state, increase ED, negative and positive are gone up and down in order; QI and blood is transferred big, and phlegm-damp has outlet, and it is normal that three high targets are able to recover.
Take medicament provided by the invention, and following acupuncture point is applied acupuncture.Fenglong acupoint: straight thrust l~1.5 cun, 10 minutes hand-manipulating of needle are 1 time at interval.DAZHUI acupoint: 0.5-1 cun of straight thrust.Baihui acupoint: 0.5-0.8 cun of flat thorn.Tsu san li: diagonal stabbing is 0.8-1.5 cun backward.Neiguan acupoint: 0.5-1 cun of straight thrust.WEIYU acupoint: the side is opened 1.5 cun.The bl cave: the side is opened 1.5 cun.
DAZHUI acupoint, Baihui acupoint, Fenglong acupoint dredging the meridian, the QI and blood regulating rouses oneself human body, regulates brain function, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, the hard eliminating stagnation that disappears, inducing QI is descending, improves blood capillary circulation and blood pressure symptom.Fenglong acupoint, tsu san li, Neiguan acupoint warming the kidney and strengthening the spleen, the YANG invigorating QI invigorating, the clots absorbing of regulating the flow of vital energy, damp eliminating is reduced phlegm, and improves the human body metabolism, promotes gastrointestinal peristalsis and bile secretion or discharge effect, can lower unusual that blood fat and blood flow change.Baihui acupoint, nei guan point, WEIYU acupoint making the adverse-rising QI downwards, promoting blood circulation and removing blood stasis, nurse one's health all sun, the cleaning head; Negative and positive are played two-way optimum conditioning, reduce the plain level of blood vessel endothelium, and play hemangiectasis; Lower the peripheral resistance effect, promote immunity of organism, coordinate nerve-endocrine function.Bl cave, WEIYU acupoint rouse oneself stops up the QI and blood that stagnates in the QI and blood dredging the meridian, coordinate deficiency and excess, the dysfunction of conditioning viscera, each internal organs functional status of two-way optimum conditioning.
The present invention filters out blood circulation promoting and blood stasis dispelling, vessel softening; By the theory of Chinese medical science prescription, skim the cream off milk, give full play to blood fat reducing viscosity reduction, vessel softening, antidotal effect; Cooperate above-mentioned acupuncture and moxibustion treatment; Can heighten the effect of a treatment, slow down the development of hyperlipidemia, hypertension, high blood viscosity, avoid the untoward reaction of Western medicine.
Through medicine provided by the invention and combine the manipulation of acupuncture, adopt the pure Chinese medicine and the manipulation of acupuncture fully, greatly reduce the misery of patient in therapeutic process, and the toxic and side effects of having avoided the Western medicine medicine that the patient is produced.Because the price of Chinese medicine ingredients and the relative Western medicine of expense of the manipulation of acupuncture are cheap, have also further reduced the treatment cost, but also have reduced patient's sickness rate and disability rate.
The specific embodiment
The method for preparing of treatment hypertension, hyperlipidemia, high blood viscosity medicine,
1) raw material of the following ratio of weight and number of preparation: Radix Salviae Miltiorrhizae 15g, Cortex Moutan 7g, Hirudo 2g, Spica Prunellae 20g, Radix Bupleuri 4.5g, Radix Rehmanniae 10g, Pericarpium Citri Reticulatae 4.5g, Cortex Magnoliae Officinalis 6g, Radix Stephaniae Tetrandrae 5g, Fructus Crataegi 9g;
2) raw material that above-mentioned weight proportion is good adopts industrial making method to be processed into the decoction of taking in a day.
One day twice, one course of treatment of first quarter moon.
Take medicament provided by the invention, following acupuncture point is applied acupuncture.Fenglong acupoint: straight thrust l~1.5 cun, 10 minutes hand-manipulating of needle are 1 time at interval.DAZHUI acupoint: 0.5-1 cun of straight thrust.Baihui acupoint: 0.5-0.8 cun of flat thorn.Tsu san li: diagonal stabbing is 0.8-1.5 cun backward.Neiguan acupoint: 0.5-1 cun of straight thrust.WEIYU acupoint: the side is opened 1.5 cun.The bl cave: the side is opened 1.5 cun.
The inventor has carried out experimental observation to the curative effect of technical scheme of the present invention.Test situation is following: the human body normal arterial pressure be systolic pressure >=140mmHg with (or) diastolic pressure >=90mmHg, can be diagnosed as hypertension.Total plasma cholesterol 5.7mmol/L, plasma triglyceride, 2.0mmol/L can be diagnosed as hyperlipidemia.
It is following to adopt this medicament to combine acupuncture therapy to carry out the clinical treatment observation situation:
1, physical data:
Male 42 examples, women 58 examples in test group 100 examples, 35 ~ 83 years old age, average (56.3 ± 6.3) year, the course of disease 4.7 ~ 17.3 years, average (8.6 ± 3.9) year.Male 49 examples, women 51 examples in the matched group 1,33 ~ 81 years old age, average (55.6 ± 5.9) year, the course of disease 5.1 ~ 16.3 years, average (9.4 ± 5.0) year.Male 46 examples, women 54 examples in the matched group 2,31 ~ 81 years old age, average (54.6 ± 5.5) year, the course of disease 5.0 ~ 17.1 years, average (9.2 ± 4.3) year.
2, the new Chinese medicine clinical research guideline that study subject is selected, efficacy determination is all formulated according to state food and drug administration.
3, administrated method, dosage and observation item
Test group: adopt the said medicament of present embodiment.One day twice, one course of treatment of first quarter moon.Cooperate above-mentioned acupuncture-moxibustion therapy method.
Contrast 1 group: only use above-mentioned acupuncture-moxibustion therapy method.Once-a-day, course of treatment of first quarter moon.
Contrast 2 groups: take Nifedipine sustained release tablets.The adult recommends following dosage: a slice (30mg), 1 time on the one.Course of treatment of first quarter moon.
Observation item: 1) empty stomach serum total cholesterol and serum total cholesterol.2) blood pressure: METHOD FOR CONTINUOUS DETERMINATION is averaged for 3 times.
4, blood, urine, just respectively do once before and after three big routines and electrocardiogram, liver function, the renal function curing.Bad and toxic reaction after the observation medication.
5, result of the test
Test group 100 examples, the responder reaches 100 examples, and effective percentage is 100%.Contrast 1 group of 100 example, responder's 67 examples, effective percentage 67%.Contrast 2 group of 100 example, responder's 83 examples, effective percentage 83%.Explain that the comparison of test group total effective rate is high according to 2 groups.The comparison of test group total effective rate is high according to 1 group.The treatment means that contrasts 1 group can be played a role.
6, toxic and side effects
Do not see obvious toxic-side effects after the test group medication.Matched group has appearance for 2 groups: dizzy, feel sick, the patient of symptoms such as constipation, weak, flush.Matched group has no adverse reaction for 1 group.
Medicament of the present invention combines acupuncture and moxibustion treatment, with the existing method that adopts western medicine hypertension, hyperlipidemia, high blood viscosity, has the advantageous feature that curative effect is obvious, effect is continual and steady, have no side effect.

Claims (4)

1. the medicine of treatment hypertension, hyperlipidemia, high blood viscosity is characterized in that, is made up of the raw material of following ratio of weight and number:
Radix Salviae Miltiorrhizae 10 ~ 20, Cortex Moutan 5 ~ 10, Hirudo 1 ~ 3, Spica Prunellae 15 ~ 25, Radix Bupleuri 3 ~ 6, the Radix Rehmanniae 9 ~ 12, Pericarpium Citri Reticulatae 3 ~ 6, Cortex Magnoliae Officinalis 3 ~ 9, Radix Stephaniae Tetrandrae 3 ~ 9, Fructus Crataegi 6 ~ 12.
2. according to the medicine of the said treatment hypertension of claim 1, hyperlipidemia, high blood viscosity, it is characterized in that, form by the raw material of following ratio of weight and number:
Radix Salviae Miltiorrhizae 14 ~ 17, Cortex Moutan 7 ~ 8, Hirudo 1.6 ~ 2.3, Spica Prunellae 18 ~ 22, Radix Bupleuri 4 ~ 5, the Radix Rehmanniae 10 ~ 11, Pericarpium Citri Reticulatae 4 ~ 5, Cortex Magnoliae Officinalis 5 ~ 7, Radix Stephaniae Tetrandrae 3 ~ 7, Fructus Crataegi 7 ~ 10.
3. according to the medicine of the said treatment hypertension of claim 1, hyperlipidemia, high blood viscosity, it is characterized in that, form by the raw material of following ratio of weight and number:
Radix Salviae Miltiorrhizae 15, Cortex Moutan 7, Hirudo 2, Spica Prunellae 20, Radix Bupleuri 4.5, the Radix Rehmanniae 10, Pericarpium Citri Reticulatae 4.5, Cortex Magnoliae Officinalis 6, Radix Stephaniae Tetrandrae 5, Fructus Crataegi 9.
4. the method for preparing of treatment hypertension, hyperlipidemia, high blood viscosity medicine is characterized in that,
1) raw material of the following ratio of weight and number of preparation: Radix Salviae Miltiorrhizae 10 ~ 20, Cortex Moutan 5 ~ 10, Hirudo 1 ~ 3, Spica Prunellae 15 ~ 25, Radix Bupleuri 3 ~ 6, the Radix Rehmanniae 9 ~ 12, Pericarpium Citri Reticulatae 3 ~ 6, Cortex Magnoliae Officinalis 3 ~ 9, Radix Stephaniae Tetrandrae 3 ~ 9, Fructus Crataegi 6 ~ 12;
2) raw material of above-mentioned preparation adopts industrial making method to be processed into tablet, powder, decoction, honeyed pill or capsule.
CN2011103368859A 2011-10-31 2011-10-31 Drug for treating hypertension, hyperlipaemia and blood hyperviscosity and preparation method thereof Pending CN102397391A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011103368859A CN102397391A (en) 2011-10-31 2011-10-31 Drug for treating hypertension, hyperlipaemia and blood hyperviscosity and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011103368859A CN102397391A (en) 2011-10-31 2011-10-31 Drug for treating hypertension, hyperlipaemia and blood hyperviscosity and preparation method thereof

Publications (1)

Publication Number Publication Date
CN102397391A true CN102397391A (en) 2012-04-04

Family

ID=45880289

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011103368859A Pending CN102397391A (en) 2011-10-31 2011-10-31 Drug for treating hypertension, hyperlipaemia and blood hyperviscosity and preparation method thereof

Country Status (1)

Country Link
CN (1) CN102397391A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102698137A (en) * 2012-06-21 2012-10-03 王杰 Composition with blood pressure reducing function and preparation method of same
CN106806526A (en) * 2016-12-29 2017-06-09 邓运春 A kind of anti-three high diseases Chinese medicine liquor and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1342477A (en) * 2000-09-11 2002-04-03 段世荣 Quick-acting hypertension capsule

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1342477A (en) * 2000-09-11 2002-04-03 段世荣 Quick-acting hypertension capsule

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102698137A (en) * 2012-06-21 2012-10-03 王杰 Composition with blood pressure reducing function and preparation method of same
CN102698137B (en) * 2012-06-21 2013-12-11 王杰 Composition with blood pressure reducing function and preparation method of same
CN106806526A (en) * 2016-12-29 2017-06-09 邓运春 A kind of anti-three high diseases Chinese medicine liquor and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102078510B (en) Chinese medicinal composition for treating coronary heart disease
CN103041336B (en) Traditional Chinese medicine composition for treating coronary heart disease
CN100998722B (en) Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia
CN102512632A (en) Chinese herbal composition for treating abnormal menstruation
CN101204481A (en) Chinese traditional medicine for chronic nephritis
CN101095768A (en) Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age
CN1994453B (en) Orally administered Chinese medicine for treating dysmenorrheal caused by qi stagnation and blood stasis
CN105012735B (en) One kind fills blood anticancer traditional Chinese medicinal composition
CN102641471B (en) Traditional Chinese medicine for treating cholelithiasis
CN102397391A (en) Drug for treating hypertension, hyperlipaemia and blood hyperviscosity and preparation method thereof
CN103028089A (en) Traditional Chinese medicine composition for treating waist pains of middle-aged and old people
CN103212044B (en) Traditional Chinese medicine composition for treating cardiovascular diseases
CN103212041B (en) Chinese medicinal composition treating coronary heart disease
CN101579507B (en) Medicine for treating gall stones and preparation method thereof
CN100998720B (en) Oral traditional Chinese medicine for treating amenorrhea of uterus stasis
CN102988632A (en) Chinese medicinal composition for treating oedematous
CN102641420B (en) Pharmaceutical composition for treating coronary heart disease
CN101244209B (en) Medicament for preventing or treating cardiovascular and cerebrovascular diseases
CN1994415B (en) Orally administered Chinese medicine for treating dysmenorrhea
CN100998829A (en) Oral administration Chinese medicine for treating brain arteriosclerosis
CN1994452A (en) Orally administered Chinese medicine for treating functional dysmenorrhea
CN100394937C (en) Medicine for preventing and treating cardiac and cerebral vascular diseases
CN104383211A (en) Traditional Chinese medicine clysis fluid for treating chronic renal insufficiency and yang deficiency-induced cold of diabetic nephropathy
CN104758888A (en) Traditional Chinese medicine composition for treating diabetes
CN103735741A (en) Traditional Chinese medicinal composition for treating gout

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Jia Ruifei

Inventor after: Zhu Xiaojuan

Inventor before: Jia Ruifei

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: JIA RUIFEI TO: JIA RUIFEI ZHU XIAOJUAN

AD01 Patent right deemed abandoned

Effective date of abandoning: 20120404

C20 Patent right or utility model deemed to be abandoned or is abandoned